Date Filed | Type | Description |
08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/10/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Sold 47,702 shares
@ $0.9108, valued at
$43.4k
|
|
07/05/2023 |
4
| Hegde Priti (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 226,464 options to buy
@ $0 Granted 109,746 options to buy
@ $0 Granted 152,376 options to buy
@ $0 |
|
07/05/2023 |
4
| Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 73,212 options to buy
@ $0 Granted 56,868 options to buy
@ $0 Granted 45,348 options to buy
@ $0 Granted 109,746 options to buy
@ $0 Granted 152,376 options to buy
@ $0 |
|
07/05/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 736,548 options to buy
@ $0 Granted 1,251,966 options to buy
@ $0 Granted 359,700 options to buy
@ $0 Granted 3,568,026 options to buy
@ $0 Granted 57,846 options to buy
@ $0 Granted 2,715,816 options to buy
@ $0 Granted 2,158,776 options to buy
@ $0 |
|
07/03/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 933,317 options to buy
@ $0 |
|
07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 981,463 options to buy
@ $0 |
|
07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2023 |
4
| Alleva Lawrence M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 1,077,756 options to buy
@ $0 |
|
07/03/2023 |
4
| MOTT DAVID M (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 1,462,927 options to buy
@ $0 |
|
07/03/2023 |
4
| Allen Andrew R (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 500,000 options to buy
@ $0 |
|
06/01/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns:
| Granted 200,646 shares
@ $0 Granted 200,647 shares
@ $0 Granted 209,931 shares
@ $0 |
|
06/01/2023 |
3
| Menzel Garry E (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC |
06/01/2023 |
3
| Hegde Priti (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC |
06/01/2023 |
3
| Allen Andrew R (Director) has filed a Form 3 on Adaptimmune Therapeutics PLC |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|